261
Participants
Start Date
February 23, 2021
Primary Completion Date
January 15, 2027
Study Completion Date
January 15, 2027
efanesoctocog alfa (BIVV001)
Pharmaceutical form:Solution for Injection Route of administration: Intravenous
Investigational Site Number : 1580003, Taichung
Investigational Site Number : 1580005, Changhua County
Investigational Site Number : 3480002, Budapest
Investigational Site Number : 0560003, Woluwe-Saint-Lambert
Investigational Site Number : 1000172, Sofia
Investigational Site Number : 0360004, Camperdown
Investigational Site Number : 0360001, Westmead
Investigational Site Number : 1000171, Plovdiv
Investigational Site Number : 3480004, Debrecen
Investigational Site Number : 0360002, South Brisbane
Investigational Site Number : 0360003, Murdoch
Investigational Site Number : 3480005, Pécs
Investigational Site Number : 7560001, Zurich
Investigational Site Number : 1580002, Taipei
New York Presbyterian Hospital/Weill Cornell Medical Center Site Number : 8400017, New York
Investigational Site Number : 2760304, Berlin
Investigational Site Number : 1580004, Taipei
Investigational Site Number : 3000001, Athens
Investigational Site Number : 2500006, Marseille
Investigational Site Number : 3800001, Milan
Investigational Site Number : 7520001, Malmo
East Carolina University -2390 Hemby Ln Site Number : 8400015, Greenville
Investigational Site Number : 7240001, Madrid
Investigational Site Number : 2500005, Brest
Children's Healthcare of Atlanta Site Number : 8400016, Atlanta
University of Florida Health Site Number : 8400008, Gainesville
Investigational Site Number : 7920001, Istanbul
Investigational Site Number : 3800003, Vicenza
Investigational Site Number : 1580001, Taichung
Investigational Site Number : 4100603, Daegu
Cincinnati Children's Hospital Medical Center Site Number : 8400012, Cincinnati
University of Michigan Medical Center Site Number : 8400006, Ann Arbor
Michigan State University School Of Med Site Number : 8400002, East Lansing
Children's Hospital Of Iowa Site Number : 8400011, Iowa City
Investigational Site Number : 2760302, Bonn
Investigational Site Number : 2500003, Lille
Investigational Site Number : 2760001, Frankfurt am Main
Investigational Site Number : 2500004, Bron
Investigational Site Number : 3800002, Napoli
Investigational Site Number : 2760002, München
Hemostasis and Thrombosis Center of Nevada Site Number : 8400001, Las Vegas
Orthopaedic Institute for Children Site Number : 8400003, Los Angeles
Children's Hospital Los Angeles Site Number : 8400009, Los Angeles
University of California San Diego Site Number : 8400007, San Diego
Investigational Site Number : 2500001, Le Kremlin-Bicêtre
Bloodworks Northwest Site Number : 8400005, Seattle
Investigational Site Number : 1560002, Beijing
Investigational Site Number : 1560006, Beijing
Investigational Site Number : 1560007, Suzhou
Investigational Site Number : 1560005, Jinan
Investigational Site Number : 1560003, Hangzhou
Investigational Site Number : 1560004, Hangzhou
Investigational Site Number : 1560001, Guangzhou
Investigational Site Number : 1560009, Kunming
Investigational Site Number : 1560010, Kunming
Investigational Site Number : 1560013, Lanzhou
Rush University Medical Center Site Number : 8400010, Chicago
Children's Research Institute Site Number : 8400013, Columbus
Children's Hospital of Wisconsin Site Number : 8400014, Milwaukee
Investigational Site Number : 0320001, CABA
Investigational Site Number : 0320002, Godoy Cruz
Investigational Site Number : 0320003, Buenos Aires
Hemocentro Campinas - UNICAMP Site Number : 0760001, Campinas
Investigational Site Number : 1240005, Hamilton
Investigational Site Number : 1240004, Hamilton
Investigational Site Number : 1240002, Ottawa
Investigational Site Number : 1240001, Toronto
Investigational Site Number : 3720001, Dublin
Investigational Site Number : 3920425, Nagoya
Investigational Site Number : 3920423, Kitakyushu-shi
Investigational Site Number : 3920426, Kawasaki-shi
Investigational Site Number : 3920422, Kashihara-Shi
Investigational Site Number : 3920421, Shinjuku-ku
Investigational Site Number : 3920424, Suginami-ku
Investigational Site Number : 5280002, Amsterdam
Investigational Site Number : 5280001, Utrecht
Investigational Site Number : 4100601, Seoul
Investigational Site Number : 4100600, Seoul
Investigational Site Number : 7240002, Esplugues de Llobregat
Investigational Site Number : 7920004, Antalya
Investigational Site Number : 7920003, Izmir
Investigational Site Number : 8260005, London
Investigational Site Number : 8260001, London
Investigational Site Number : 8260003, Birmingham
Investigational Site Number : 8260004, Hampshire
Bioverativ, a Sanofi company
INDUSTRY